Brodimoprim
![]() | |
| Clinical data | |
|---|---|
| ATC code | J01EA02 (WHO) |
| Identifiers | |
| |
| CAS Number |
56518-41-3 |
| PubChem (CID) | 68760 |
| ChemSpider |
62004 |
| UNII |
V1YC7T6LLI |
| KEGG |
D07238 |
| ChEBI | CHEBI:131726 |
| ChEMBL |
CHEMBL31891 |
| ECHA InfoCard | 100.054.745 |
| Chemical and physical data | |
| Formula | C13H15BrN4O2 |
| Molar mass | 339.188 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
This article is issued from Wikipedia - version of the 4/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
